PharmaPrint Offering
- Share via
Dow Jones
IRVINE — PharmaPrint Inc.’s public offering of 2.25 million common shares was priced at $10.50 a share.
The company, which develops natural medicines, said CIBC Oppenheimer Corp. acted as the offering’s underwriter, and has 30 days to exercise an over-allotment option for up to an additional 337,500 shares.
PharmaPrint stock closed Wednesday at $10.94 a share, down 25 cents.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
